Phase I/II clinical study of GW572016 (lapatinib ditosylate monohydrate) in combination with trastuzumab in patients with breast cancer previously treated with trastuzumab
Phase of Trial: Phase I/II
Latest Information Update: 20 Jan 2017
At a glance
- Drugs Lapatinib (Primary) ; Trastuzumab
- Indications Breast cancer
- Focus Adverse reactions; Biomarker; Therapeutic Use
- Sponsors GlaxoSmithKline
- 20 May 2011 Actual end date changed from Nov 2008 to Dec 2007 as reported by ClinicalTrials.gov.
- 14 Oct 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Apr 2008 Status changed from recruiting to in progress, according to ClinicalTrials.gov.